Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Clin Pathol ; 52(11): 820-4, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10690171

ABSTRACT

AIM: To determine the interobserver variation in scoring presence and grade of vulvar intraepithelial neoplasia (VIN) in haematoxylin/eosin (H/E) slides, MIB 1 slides, and the combined use of H/E and MIB 1 slides. METHODS: 10 slides were stained with H/E and MIB 1 with each of the following diagnoses: normal vulvar skin, VIN 1, VIN 2, and VIN 3. Six observers first scored the H/E slides separately from the MIB 1 slides and second the combined H/E and MIB 1 slides. RESULTS: Unweighted group kappa for MIB 1 was 0.62 and the weighted group kappa was 0.91. This was significantly better than the unweighted group kappa for H/E slides (0.47, p = 0.023) as well as the weighted group kappa for H/E slides (0.82, p = 0.014). There was no improvement by the combined use of H/E and MIB 1 slides. VIN 2 is far less confused with VIN 3 in the combined use of H/E and MIB 1 slides (9%) than in H/E slides (38%) (p = 0.007). There is a tendency to grade VIN in a two tailed grading system rather than a three tailed grading system, which became more apparent with the combined use of H/E and MIB 1 slides. CONCLUSIONS: The interobserver variation with sole use of MIB 1 is better than with the use of H/E stain in VIN. The use of MIB 1 in grading VIN diminishes confusion between VIN 2 and VIN 3 fourfold. A two tailed grading system for VIN seems already to work in daily practice.


Subject(s)
Antigens, Neoplasm/analysis , Carcinoma in Situ/pathology , Ki-67 Antigen/analysis , Vulvar Neoplasms/pathology , Antibodies, Monoclonal , Antigens, Nuclear , Carcinoma in Situ/immunology , Eosine Yellowish-(YS) , Female , Hematoxylin , Humans , Nuclear Proteins/immunology , Observer Variation , Sensitivity and Specificity , Vulva/immunology , Vulvar Neoplasms/immunology
2.
Differentiation ; 42(2): 124-9, 1989 Dec.
Article in English | MEDLINE | ID: mdl-2483838

ABSTRACT

Using specific monoclonal antibodies (DE-K10 and DE-SCK respectively), the expression of some differentiation-related epidermal keratins was studied in 38 human vulvar squamous carcinomas. In the epidermis, expression of keratin 10 (K10) strictly paralleled the extent of differentiation; it was absent in the basal layer, appeared in the first suprabasal layers and increased in concentration towards the granular layer. However, K10 was rarely detected (1 case out of 12) in early stages of vulvar squamous carcinomas (tumours less than 2 cm, clinical stage I) regardless of the tumour grade. In larger and more advanced tumours (greater than 2 cm, clinical stages II and III), K10 was detected in 21 out of 26 cases. Its expression appeared to be related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. Occasionally however, cells that did not show histological signs of keratinisation were also K10-positive. Modified stratum corneum keratins (recognized specifically by monoclonal antibody DE-SCK) were detected in the most keratinized areas (horn pearls and their close vicinity) of some K10-positive tumours, i.e., in a pattern close to their normal expression in terminally differentiated epidermal cells. These data suggest differences in the regulation of K10 expression during the differentiation processes in the normal keratinising squamous epithelium and in squamous carcinomas. While the normal pattern of vulvar epithelial differentiation is accompanied by an increasing expression of K10, malignant keratinocytes, also when these are histologically moderately or well differentiated, cease expressing this keratin in the early stages of tumour development.


Subject(s)
Carcinoma, Squamous Cell/metabolism , Keratins/metabolism , Vulvar Neoplasms/metabolism , Antibodies, Monoclonal , Carcinoma, Squamous Cell/classification , Female , Humans , Immunohistochemistry , Vulvar Neoplasms/classification
3.
Eur J Surg Oncol ; 14(2): 165-70, 1988 Apr.
Article in English | MEDLINE | ID: mdl-3360158

ABSTRACT

Seventy patients surgically treated in The Netherlands Cancer Institute between 1969 and 1984 for cutaneous melanoma of the head and neck were reviewed with regard to patient data, tumor site, stage, histological criteria, treatment, disease-control and survival. The objectives of the study were to analyse the results of curative treatment of cutaneous melanoma of the head and neck, the value of prognostic factors and the treatment policy for the N0 and N+ neck. Tumor thickness (Breslow Index) was by far the most important prognostic factor in cutaneous melanoma of the head and neck. Other known important factors like level of invasion, tumor subsite, stage, tumor type and ulceration provided additional information. Elective node dissection is advised in lesions thicker than 1.5 mm since N0-N+ transformation is seen in 37% of these patients. Partial neck dissection which includes removal of the nodes adjacent to the primary provides proper regional control except for primary lesions in the neck that require at least a modified neck dissection.


Subject(s)
Head and Neck Neoplasms/mortality , Melanoma/mortality , Skin Neoplasms/mortality , Adult , Female , Head and Neck Neoplasms/pathology , Head and Neck Neoplasms/surgery , Humans , Lymph Node Excision , Lymphatic Metastasis , Male , Melanoma/pathology , Melanoma/surgery , Middle Aged , Prognosis , Skin Neoplasms/pathology , Skin Neoplasms/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...